ITMI20052327A1 - Lisozima umano ricombinante modificato - Google Patents

Lisozima umano ricombinante modificato

Info

Publication number
ITMI20052327A1
ITMI20052327A1 IT002327A ITMI20052327A ITMI20052327A1 IT MI20052327 A1 ITMI20052327 A1 IT MI20052327A1 IT 002327 A IT002327 A IT 002327A IT MI20052327 A ITMI20052327 A IT MI20052327A IT MI20052327 A1 ITMI20052327 A1 IT MI20052327A1
Authority
IT
Italy
Prior art keywords
lisozyme
recombinant human
modified recombinant
modified
human
Prior art date
Application number
IT002327A
Other languages
English (en)
Inventor
Pablo E A Rodriguez
Paolo Alberto Veronesi
Original Assignee
Therapicon Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therapicon Srl filed Critical Therapicon Srl
Priority to IT002327A priority Critical patent/ITMI20052327A1/it
Priority to US12/096,511 priority patent/US20080286257A1/en
Priority to PCT/EP2006/066941 priority patent/WO2007065743A1/en
Priority to EP06793936A priority patent/EP1968640A1/en
Publication of ITMI20052327A1 publication Critical patent/ITMI20052327A1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2462—Lysozyme (3.2.1.17)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
IT002327A 2005-12-06 2005-12-06 Lisozima umano ricombinante modificato ITMI20052327A1 (it)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IT002327A ITMI20052327A1 (it) 2005-12-06 2005-12-06 Lisozima umano ricombinante modificato
US12/096,511 US20080286257A1 (en) 2005-12-06 2006-09-29 Compounds for Use in Treating Abnormal Cell Proliferation, and Methods of Producing Same
PCT/EP2006/066941 WO2007065743A1 (en) 2005-12-06 2006-09-29 Compounds for use in treating abnormal cell proliferation, and methods of producing same
EP06793936A EP1968640A1 (en) 2005-12-06 2006-09-29 Compounds for use in treating abnormal cell proliferation, and methods of producing same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002327A ITMI20052327A1 (it) 2005-12-06 2005-12-06 Lisozima umano ricombinante modificato

Publications (1)

Publication Number Publication Date
ITMI20052327A1 true ITMI20052327A1 (it) 2007-06-07

Family

ID=37460068

Family Applications (1)

Application Number Title Priority Date Filing Date
IT002327A ITMI20052327A1 (it) 2005-12-06 2005-12-06 Lisozima umano ricombinante modificato

Country Status (4)

Country Link
US (1) US20080286257A1 (it)
EP (1) EP1968640A1 (it)
IT (1) ITMI20052327A1 (it)
WO (1) WO2007065743A1 (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20061950A1 (it) * 2006-10-11 2008-04-12 Therapicon Srl Effetto antimetastatico in condizioni patologiche delle cellule umane
CN109528498B (zh) * 2018-12-30 2021-05-18 美釉(西安)生物技术有限公司 一种用于深入封闭牙小管并防止生物膜形成的牙齿脱敏剂

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI981148A1 (it) * 1998-05-22 1999-11-22 Therapicon Srl Utilizzo di lisozima c modificato per preparare composizioni medicinali per il trattamento di alcune gravi malattie
JP2002532060A (ja) * 1998-08-31 2002-10-02 ロン ユー， 新規なヒトリゾチーム遺伝子、それによりコードされたポリペプチド、およびそれらの作製方法

Also Published As

Publication number Publication date
EP1968640A1 (en) 2008-09-17
US20080286257A1 (en) 2008-11-20
WO2007065743A1 (en) 2007-06-14

Similar Documents

Publication Publication Date Title
CY2014030I1 (el) Θεραπευτικες συνθεσεις που περιλαμβανουν ingenol-3-angelate
DK1959991T3 (da) Terapeutisk vaccine
ATE525088T1 (de) Kombinationstherapie
FR2887132B3 (fr) Matelas combine
DE602005026825D1 (de) Endoskop
DE602006009763D1 (de) Iontophoresegerät
DK1863899T3 (da) Hudbehandlingspræparater
DK2035447T3 (da) Polypeptid
DK1804871T3 (da) Forbedret mellemstykke
DE602006003063D1 (de) Tripeptid- und tetrapeptidsulfone
DK2035369T3 (da) Terapeutiske
SE0501138L (sv) Joystick arrangement
DE602005026124D1 (de) Endoskop
DK1968623T3 (da) Bacteriocin-inducer-peptider
DK2119472T3 (da) Hud-/hårbehandlingssystem
GB0526120D0 (en) Therapeutic peptides
DE602005005655D1 (de) Massagebett
UY3587Q (es) Unidad arítmetica y de control
ITMI20052327A1 (it) Lisozima umano ricombinante modificato
FI20050453A0 (fi) Ihonhoitokoostumus
ITPD20050023U1 (it) Impedenzimetro corporeo
FI6726U1 (fi) Hieromalaite
FR2871542B3 (fr) Soupage spherique
DE502005004692D1 (de) Massageaufsatz
ATA13282004A (de) Massagegerät